►教育、工作经历
1996-2000年 硕士 中国药科大学药物制剂
2002-2005年 博士 中国药科大学药物制剂
2000.11-2002.3 国家药品审评中心
2005,11-2006,8 香港浸会大学访问学者
2010.7-2011.12 江苏四环生物股份有限公司 技术总监（企业柔性人才挂职）
2002.4- 至今 中国药科大学药学院药剂教研室，中国药科大学-震元制药制剂合作开发实验室负责人
►主要研究方向
1）药物晶体工程
2）共晶及共无定型理论与技术
3）新液晶材料及其给药系统
4）缓控释制剂技术
5）纳米制剂技术
►基本情况
副教授，硕士生导师，国家食品药品监督管理局药品审评专家，2010年获中国药学会-石药青年药剂学奖。
主持了逾40余项校企合作课题的研究与产业化，研究剂型及技术全面，在应用技术领域及制剂生产第一线，在推动技术创新和科技成果转化等方面有非常丰富的产品研发经验和产业化经验。目前已申请专利30余项，已授权15项，转让4项。
注重药物制剂理论基础尤其是药物晶体学的深入研究，重视新技术、新剂型的应用基础，近年来在上述研究方向上发展迅速，发表SCI论文20余篇，国内EI及核心期刊论文几十篇，《中药制剂新剂型与新技术》的副主编，并参与编写了《药剂学》、《药剂学实验》等多部教材。
►代表性文章
1 Zhang J,Gao Y,Qian S,Liu X,Zu H. Physicochemical and pharmacokinetic characterization of a spray-dried malotilate emulsion. Int J Pharm. 2011,414(1-2):186-192.
2 Liu Y,Zhang J (contribution equally),Gao Y,Zhu J. Preparation and evaluation of glyceryl monooleate-coated hollow-bioadhesive microspheres for gastroretentive drug delivery. Int J Pharm. 2011,413(1-2):103-109.
3 Gao Y,Qian S,Zhang J. Physicochemical and pharmacokinetic characterization of a spray-dried cefpodoxime proxetil nanosuspension. Chem Pharm Bull. 2010,58(7): 912-917.
4 Zhang J,Gao Y,Su F,Gong Z,Zhang Y. Interaction characteristics with bovine serum albumin and retarded nitric oxide release of ZCVI(4)-2,a new nitric oxide-releasing derivative of oleanolic acid. Chem Pharm Bull. 2011,59(6): 734-741.
5 Gao Y,Zu H,Zhang J*. Enhanced dissolution and stability of adefovir dipivoxil by cocrystal formation. J Pharm Pharmacol. 2011,63(4): 483–490.
6 Zhang J,Zu H,Gao Y. Formation thermodynamics of adefovir dipivoxil-saccharin co-crystals. Acta Phys Chim Sin. 2011,27(3): 547-552.
7 Gao Y,Zu H,Zhang J*. Pharmaceutical cocrystals. Prog Chem. 2010,22(5): 829-836.
8 Gao Y,Sun WJ,Zhang J*. Optimization of preparation and property studies on glycosylated albumin as drug carrier for nanoparticles. Pharmazie. 2011,66(7): 484-490.
9 Gao Y,Sun WJ,Zhang J*. Albumin as drug carriers. Prog Chem. 2011,23(8): 168-176.
10 Zhang J,Li C,Gao Y. Effect of poloxamer F 127 and paeonol on GMO-based liquid crystal transformation. Acta Chim Sin. 2011,69(13): 1503-1508.
11 Zhang J,Lv H,Jiang K,Gao Y. Enhanced bioavailability after oral and pulmonary administration of baicalein nanocrystal. Int J Pharm. 2011,420(1):180-188.
12 Zhang J,Zheng Z,Gao Y,Zhang Y. Spray-dried oil-in-water emulsion to improve the intestinal absorption and oral bioavailability of ZLR-8,a nitric oxide-releasing derivative of diclofenac. J Pharm Pharmacol. 2011,63(12):1531-1538.
13 Gao Y,Li L,Zhang J*,Su F,Gong Z,Lai Y,Zhang Y. Physicochemical characterization and an injection formulation study of water insoluble ZCVI4-2，a novel NO-donor anti-cancer compound. Arch Pharm Res. 2012,35(7): 1177-1186.
14 Zhang J,Li L,Gao Y,Fan W. Development and validation of a stability indicating hplc method for the analysis of lornoxicam inEnd Match powder for injection. Pak J Pharm Sci. 2012,25(2): 371-375.
15 Gao Y,Li L,Zhang J*,Shu W,Gao L. Simultaneous determination of triacetin,acetic ether,butyl acetate and amorolfine hydrochloride in amorolfine liniment by HPLC. Pak J Pharm Sci. 2012,25(2): 389-394.
16. Zhang J,Liu D,Huang Y,Gao Y,Qian S. Biopharmaceutics classification and intestinal absorption study of apigenin. Int J Pharm. 2012,436(1-2): 311-317.
17. Gao Y,Gao J,Liu Z,Kan H,Zu H,Sun W,Zhang J*,Qian S. Coformer selection based on degradation pathway of drugs: a case study of adefovir dipivoxil-saccharin and adefovir dipivoxil-nicotinamide cocrystals. Int J Pharm. 2012,438(1-2): 327-335
18. Zhang J,Tan X,Gao J,Fan W,Gao Y,Qian S. Polymorphism of lornoxicam. J Pharm Pharmacol. 2013,65(1): 44-52.
19. Zhang J,Huang Y,Liu D,Gao Y,Qian S. Preparation of apigenin nanocrystals using supercritical antisolvent process for dissolution and bioavailability enhancement. Eur J Pharm Sci. 2013,48(4–5): 740–747.
20. Y Gao,J Liao,X Qi,J Zhang*.Coamorphous repaglinide–saccharin with enhanced dissolution. Int J Pharm. 2013,450(1-2): 290-295.
►联系方式
myamicute@163.com
免责声明
本文章来源为院校研究生官网，如对稿件内容有疑问，请与院校招生办联系。培训啦转载出于非商业性的教育和科研之目的，不代表赞同其观点或证实其内容的真实性。如转载稿涉及版权等问题，请来函136311265@qq.com联系修改或删除。
温馨提示：
